{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12692173",
  "DateCompleted": {
    "Year": "2004",
    "Month": "01",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2003",
        "Month": "04",
        "Day": "11"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-3751",
      "JournalIssue": {
        "Volume": "549",
        "Issue": "Pt 2",
        "PubDate": {
          "Year": "2003",
          "Month": "Jun",
          "Day": "01"
        }
      },
      "Title": "The Journal of physiology",
      "ISOAbbreviation": "J Physiol"
    },
    "ArticleTitle": "Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.",
    "Pagination": {
      "StartPage": "653",
      "EndPage": "664",
      "MedlinePgn": "653-64"
    },
    "Abstract": {
      "AbstractText": [
        "We tested the hypothesis that endogenous interleukin (IL)-10 limits the fever induced by a Gram-negative bacterial toxin (Escherichia coli lipopolysaccharide, LPS) and a Gram-positive bacterial toxin (Staphylococcus aureus), when these toxins are injected into a subcutaneous air pouch (I.PO.) in rats. Injection of LPS or S. aureus caused fevers that were reduced in amplitude and duration by simultaneous administration of rat recombinant IL-10. The inhibition of fever by IL-10 was accompanied by a significant reduction in the toxin-evoked increases in concentrations of immunoreactive IL-6 at the site of inflammation and of IL-6 and IL-1 receptor antagonist in the circulation. Conversely, neutralisation of endogenous IL-10 in the pouch increased the amplitude and dramatically increased the duration of toxin-evoked fever, and augmented toxin-induced increases in pouch tumour necrosis factor-alpha, IL-1beta, and especially IL-6. Our data support a crucial regulatory role for endogenous IL-10 in limiting the fever responses during both Gram-negative and Gram-positive infections."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK. tcartmel@nibsc.ac.uk"
          }
        ],
        "LastName": "Cartmell",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ball",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bristow",
        "ForeName": "A F",
        "Initials": "AF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mitchell",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Poole",
        "ForeName": "S",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Physiol",
    "NlmUniqueID": "0266262",
    "ISSNLinking": "0022-3751"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-6"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Lipopolysaccharides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Recombinant Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Tumor Necrosis Factor-alpha"
    },
    {
      "RegistryNumber": "130068-27-8",
      "NameOfSubstance": "Interleukin-10"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "etiology",
        "metabolism",
        "physiopathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "complications",
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Interleukin-1"
    },
    {
      "QualifierName": [
        "metabolism",
        "pharmacology"
      ],
      "DescriptorName": "Interleukin-10"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Interleukin-6"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lipopolysaccharides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Osmolar Concentration"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Sprague-Dawley"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Recombinant Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Staphylococcal Infections"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Subcutaneous Tissue"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Tumor Necrosis Factor-alpha"
    }
  ]
}